Tenders Are Invited For Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Agreement In Accord ... in Germany

Work Detail

Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Or Section 130C Paragraph 8 Sgb V For Patent-Protected Active Ingredients-Vv93. Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Anakinra - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Ciclosporin S01xa18 (Vevizye & Cequa) - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Clostridium Botulinum Toxin Type A (Botox) - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130C Paragraph 1 Sgb V For The Active Ingredient Etrasimod - Vv93,Conclusion Of A Non-Exclusive Discount Agreement According To Section 130C Paragraph 1 Sgb V For The Active Ingredient Allergen Extract (Grazax) - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Pegvisomant - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130C Paragraph 1 Sgb V For The Active Ingredient Ponesimod - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130C Paragraph 1 Sgb V For The Active Ingredient Propranolol (Hemangiol) - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Rilpivirine (Fta) - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130C Paragraph 1 Sgb V For The Active Ingredient Risankizumab - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130C Paragraph 1 Sgb V For The Active Ingredient Siponimod - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Somatropin (Humatrope/Norditropin/Saizen) - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tiotropium (Inl) - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Combination Tiotropium + Olodaterol - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Interferon Beta-1B (Betaferon) - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Triptorelin (Pamorelin) - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Ozanimod - Vv93,Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Filgotinib - Vv93

Contact Information